×
Cerus EBIT 2010-2025 | CERS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cerus ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
View More
Cerus EBIT 2010-2025 | CERS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Cerus ebit from 2010 to 2025. Ebit can be defined as earnings before interest and taxes.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$220.2B
Boston Scientific (BSX)
$157B
Stryker (SYK)
$154B
EssilorLuxottica (ESLOY)
$136.6B
Medtronic (MDT)
$119.2B
Lonza Group Ag (LZAGY)
$50.3B
Haleon (HLN)
$44.4B
ResMed (RMD)
$40.3B
GE HealthCare Technologies (GEHC)
$35.5B
Agilent Technologies (A)
$34.1B
Terumo (TRUMY)
$25.8B
Koninklijke Philips (PHG)
$25.2B
Insulet (PODD)
$20.4B
Zimmer Biomet Holdings (ZBH)
$19.3B
Baxter (BAX)
$15B
Smith & Nephew SNATS (SNN)
$13.9B
Sunny Optical Technology (SNPTF)
$10.4B
Demant (WILYY)
$8.6B
Bio-Rad Laboratories (BIO)
$7.2B
Lantheus Holdings (LNTH)
$5B
Perrigo (PRGO)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.8B
Haemonetics (HAE)
$3.6B
Envista Holdings (NVST)
$3.5B
Shandong Weigao Medical Polymer (SHWGF)
$3.5B
ICU Medical (ICUI)
$3.2B
LeMaitre Vascular (LMAT)
$1.9B
QuidelOrtho (QDEL)
$1.9B
AtriCure (ATRC)
$1.6B
Acuren (TIC)
$1.4B